A Novel MYH9-RET Fusion Occurrence and EGFR T790M Loss as an Acquired Resistance Mechanism to Osimertinib in a Patient with Lung Adenocarcinoma: A Case Report

Sun Y, Pei L, Luo N, Chen D, Meng L

OncoTargets and Therapy 2020, 13:11177-11181

Published Date: 2 November 2020